Comparison between Rivaroxaban vs Apixaban
| Parameter | Rivaroxaban | Apixaban |
|---|---|---|
| Class | DOAC Xa inhibitor | DOAC Xa inhibitor |
| Mechanism | Factor Xa inhibition | Factor Xa inhibition |
| Onset | Rapid | Rapid |
| Monitoring | None | None |
| Dosing | OD/BID fixed | BID fixed |
| Half-life | 5-13h | ~12h |
| Reversal Agent | Andexanet | PCC/Andexanet |
| Bleeding Risk | GI higher | Lower bleed |
| Indications | AF/VTE | AF/VTE |
| Renal Use | Caution | Better renal profile |
| Pregnancy Use | Avoid | Avoid |
| Drug Interactions | CYP3A4 | P-gp |
| Adherence Sensitivity | High | High |
| Best Use Case | Once daily | BID stable |
| Cost | High | High |
| Monitoring Burden | Low | Low |
| Clinical Flexibility | Moderate | Moderate |
| Real-world Convenience | High | High |
| Overall Verdict | Convenient | Safer bleeding |
| Food Interactions | None | None |